Weekly News Recap #Phispers
Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda’s antipsychotic pill for bipolar disorder, schizophrenia
In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...
Impressions : 945
Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon
In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...
Impressions : 1328
FDA to consider psychedelic-assisted drug for treating PTSD; Novartis buys Mariana Oncology for up to US$ 1.75 bn
Last year, the US Food and Drug Administration (FDA) had published a new draft guidance for researchers investigating the use o...
Impressions : 1153
Sanofi-GSK join hands for Covid-19 vaccine; BMS awarded US$ 1.2 billion in major patent case win over Gilead
This week, Phispers brings you news about two key competitors in the field of vaccines — Sanofi and GSK — joining h...
Impressions : 2143
Chinese plant littered with rodent feces supplied OTC products to US; Recipharm acquisition spree continues
In Phispers this week, we bring you news about US retailer Greenbrier International being issued an FDA warning letter for sour...
Impressions : 4093
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.